EntityMap — Ketalux

A structured, entity-first index of Ketalux content for AI agents and LLMs, following the EntityMap v1.0 specification.

View machine-readable entitymap.json →

Publisher

Ketaluxhttps://ketalux.com
sameAs: Wikipedia: Ketamine

Entities

ConceptKetamine

A dissociative anesthetic medication studied for rapid-acting antidepressant effects and used in supervised mental health treatment protocols.

Relations: TREATS → Major Depressive Disorder; TREATS → PTSD; ACTS_ON → NMDA Receptor

MethodologyKetamine-Assisted Psychotherapy

A clinical protocol combining supervised ketamine administration with psychotherapy sessions to support integration of the experience.

ConceptMajor Depressive Disorder

A mood disorder characterized by persistent low mood and functional impairment, studied as a target for ketamine therapy.

ConceptPost-Traumatic Stress Disorder

A trauma-related disorder researched as a potential target for ketamine-based interventions alongside trauma-focused therapy.

ConceptAnxiety Disorders

Mental health conditions including generalized anxiety studied in the context of ketamine therapy research.

ConceptObsessive-Compulsive Disorder

A mental health condition explored as an investigational target for ketamine treatment.

ConceptEsketamine

The S-enantiomer of ketamine, available as an intranasal formulation approved for treatment-resistant depression.

ConceptNMDA Receptor

A glutamate receptor central to ketamine's pharmacological action, implicated in synaptic plasticity.

ConceptNeuroplasticity

The brain's capacity to reorganize synaptic connections, hypothesized to underlie ketamine's sustained therapeutic effects.

ConceptBrain-Derived Neurotrophic Factor

A neurotrophin involved in neuronal growth and plasticity, implicated in mTOR-mediated mechanisms of ketamine response.

MethodologyIntravenous Ketamine Infusion

A clinical modality delivering subanesthetic ketamine doses via IV infusion under medical monitoring.

ConceptKetamine Safety and Contraindications

Clinical considerations covering side effects, drug interactions, and patient populations for whom ketamine is not appropriate.